Fullerene Therapeutics Inc. is a privately held neuroscience pharmaceutical company headquartered in New York, NY. Our focus is on further research and commercialization of Carboxyfullerenes, starting first with a therapeutic drug called C3 that has shown promise in the treatment of Central Nervous System diseases in preclinical and development stage research.  We have ongoing research arrangements with the University of California at San Diego, as well as development and manufacturing arrangements in Bavaria, Germany.

Copyright 2019 Fullerene Therapeutics, Inc.
No part of the contents of this web site may be 
reproduced without express written permission.